Robert Kneschke/Shutterstock Samuel J. White, Nottingham Trent University and Philippe B. Wilson, Nottingham Trent University It’s estimated that up to 42% of people suffer from hay fever symptoms, which can range from mild to severe. While most hay fever sufferers will get relief from treatments such as antihistamines, nasal sprays, and eye drops, this is not the case for everyone. …Read More »
Health & Medicine
COVID vaccines: should people under 50 in the UK be offered a fourth dose?
Studio Romantic/Shutterstock Alessandro Siani, University of Portsmouth It’s been nearly two years since Margaret Keenan became the first person in the world to receive an approved COVID vaccine at a clinic in Coventry on December 8, 2020. Since then, almost 13 billion doses of various COVID vaccines have been administered globally. And they are estimated to have prevented millions of …Read More »
Pancreatic cancer could be diagnosed up to three years earlier – new study
Magic mine/Shutterstock Agnieszka Lemanska, University of Surrey Every year, more than 10,000 people in the UK are diagnosed with pancreatic cancer. Unfortunately, for most of those people, the disease is diagnosed too late to be cured. Less than 10% of people live five years following a diagnosis. Pancreatic cancer is a silent disease. For many people, it has no symptoms …Read More »
Cancer in the under 50s is rising, globally – why?
Siobhan Glavey, RCSI University of Medicine and Health Sciences We know what we need to do to reduce our risk of getting cancer, right? Wear SPF, stop smoking, avoid processed foods, keep fit, lose weight and get enough sleep. But what if much of what causes cancer has already happened in our early years, or worse still, before we were …Read More »
Psychedelic drugs: how to tell good research from bad
James Rucker, King’s College London Research with psychedelic drugs has made a dramatic comeback amid a heady mix of softening societal attitudes, the lure of commercial opportunity, misgivings about the “war on drugs”, and the desire to develop new ways to treat mental health conditions. So you might have read in the media that there’s a new study which shows …Read More »
Four health conditions linked to gum disease
Early symptoms of gum disease include red, swollen gums, and bleeding when you brush or floss your teeth. Creative Cat Studio/ Shutterstock Christine Bryson, Anglia Ruskin University Gum diseases are among the most common chronic human diseases, affecting between 20 to 50% of people worldwide. They happen when plaque, a sticky film of bacteria, builds up on teeth. The earliest …Read More »
Haven’t had COVID yet? It could be more than just luck
I Wei Huang/Shutterstock Lindsay Broadbent, Queen’s University Belfast We all know a few of those lucky people who, somehow, have managed to avoid ever catching COVID. Perhaps you’re one of them. Is this a Marvel-esque superpower? Is there any scientific reason why a person might be resistant to becoming infected, when the virus seems to be everywhere? Or is it …Read More »
Monkeypox may cause neurological damage, including inflammation of the brain – new study
James Brunton Badenoch, Queen Mary University of London Monkeypox’s effect on the skin – the disfiguring rashes – and the flu-like symptoms have been well described, but few have investigated the neurological and psychiatric problems the virus might cause. There are historic reports of neurological complications in people infected with the related smallpox virus and in people vaccinated against smallpox, …Read More »
Coronary artery stents show no benefit in treating heart failure – landmark trial
Photo Oz/Shutterstock Matthew Ryan, King’s College London Every year, 60,000 people in the UK are diagnosed with heart failure, and many are treated with stents. In a large new study published in the New England Journal of Medicine, my colleagues and I discovered that these procedures are unnecessary. Heart failure is where the heart muscle becomes weakened, leading to symptoms …Read More »
Better COVID vaccines are on the way. What do they do? And what technology might we see in future?
Unsplash/CDC Paul Griffin, The University of Queensland Regulators in Australia and the United States last week approved Omicron-specific boosters, following approval in the United Kingdom in mid-August. In Australia, a Moderna Omicron booster has been provisionally approved for use in adults aged 18 and over. Supplies are expected to arrive in the coming weeks, however the Australian Technical Advisory Group …Read More »